Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

All NewsMarch 20, 2026

Bionano Genomics, Inc. (BNGO) will release Q4 earnings on March 23. Analysts expect $1.40 loss per share on $7.85M revenue. Stock closed at $1.12.

Latest Ratings for BNGO

DateFirmActionFromTo Jun 2021BTIGInitiates Coverage OnBuy Dec 2020Roth CapitalDowngradesBuyNeutral Sep 2020Ladenburg ThalmannInitiates Coverage OnBuy

View More Analyst Ratings for BNGO

View the Latest Analyst Ratings

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent